Latigo Biotherapeutics logo

Latigo Biotherapeutics Funding & Investors

Thousand Oaks, CA

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependence or tolerability.

latigobio.com

Total Amount Raised: $300,000,000

Latigo Biotherapeutics Funding Rounds

  • Series B

    $150,000,000

    Series B Investors

    Blue Owl
    KERN CAPITAL HOLDINGS PTY
    sanofi-aventis
    Qatar Investment Authority
    Deep Track Capital
    UPMC
    Rock Springs Capital
    Access Industries
    Cormorant Asset Management
    Alexandria Venture Investments
    Westlake Village BioPartners
    5am Ventures
    Foresite Capital
  • Series A

    $135,000,000

    Series A Investors

    5am Ventures
    Foresite Capital
    Westlake Village BioPartners
    Corner Ventures
  • Series Unknown

    $15,000,000

    Series Unknown Investors

    Corner Ventures
Funding info provided by Diffbot.